Recurrent toxocariasis due to chronic urticaria and successful treatment with prolonged albendazole therapy.

Abstract

Toxocariasis is a worldwide human helminthiasis, especially seen in temperate and tropical climate regions around the world. The diagnosis of this disease is performed on the basis of clinical symptoms and laboratory findings. Albendazole is one of the treatment choices for toxocariasis, with a currently recommended regimen of 10 mg/kg/day in two doses (400 mg twice daily) for 5 days. However, there is no precise consensus about the duration of the treatment. In this article, we report a case of toxocariasis; the patient visited our infectious disease polyclinic with complaints of long-term itching and urticarial skin lesions that were resistant to routine treatment and that recurred. Then, recurrent disease was resolved and skin lesions were diminished after prolonged albendazole therapy.

• Authors: Ergenekon Karagöz, Mehmet Burak Selek, Ersin Aydın, Mustafa Hatipoğlu, Vedat Turhan, Ali Acar, Oral Öncül, Levent Görenek
• Journal: Turkiye parazitolojii dergisi (Turkiye Parazitol Derg) Vol. 39 Issue 1 Pg. 83-5 (Mar 2015) ISSN: 2146-3077 [Electronic] Turkey
• PMID: 25917592 (Publication Type: Journal Article)

Chemical References

• Anthelmintics
• Albendazole

Topics

• Albendazole (administration & dosage, therapeutic use)
• Animals
• Anthelmintics (administration & dosage, therapeutic use)
• Chronic Disease
• Diagnosis, Differential
• Humans
• Male
• Pruritus (diagnosis, parasitology)
• Recurrence
• Time Factors
• Toxocariasis (diagnosis, drug therapy)
• Urticaria (diagnosis, parasitology)